Nemluvio 30 MG pens
Ended Awarded Last action
- Contract number
- SPE2DR26FCT0R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,033
Award facts
- Contract value 100% obligated
- $2,033.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $2,033.08 delivery order (Contract No. 4570183569) to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens, with an ultimate completion date of December 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse pharmaceutical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This specific delivery order for Nemluvio, a specialty medication, exemplifies the company's role as a primary pharmaceutical supplier within the DLA's medical supply chain infrastructure, supporting the agency's mission to provide comprehensive pharmaceutical support to federal healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FCT0R?
SPE2DR26FCT0R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FCT0R worth?
The government has obligated $2,033 on SPE2DR26FCT0R.
Is contract SPE2DR26FCT0R an order under another contract?
Yes. SPE2DR26FCT0R is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCT0R competed?
The extent of competition for SPE2DR26FCT0R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award